MX2021005421A - Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos. - Google Patents

Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos.

Info

Publication number
MX2021005421A
MX2021005421A MX2021005421A MX2021005421A MX2021005421A MX 2021005421 A MX2021005421 A MX 2021005421A MX 2021005421 A MX2021005421 A MX 2021005421A MX 2021005421 A MX2021005421 A MX 2021005421A MX 2021005421 A MX2021005421 A MX 2021005421A
Authority
MX
Mexico
Prior art keywords
membered macrolides
macrolides
membered
cyclic substituted
methods
Prior art date
Application number
MX2021005421A
Other languages
English (en)
Spanish (es)
Inventor
Roger B Clark
Andrew G Myers
Peter Niels Carlsen
Richard Alm
Wesley Francis Austin
Philip Hogan
Ivan Jewett
Sushmita D Lahiri
Jonathan F Lawrence
Xiben Li
Shuhao Shi
Wenying Wang
Yoshitaka Ichikawa
Ziyang Zhang
Md Ataur Rahman
Vijaya Gondi
Original Assignee
Zikani Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zikani Therapeutics Inc filed Critical Zikani Therapeutics Inc
Publication of MX2021005421A publication Critical patent/MX2021005421A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
MX2021005421A 2018-11-19 2019-11-18 Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos. MX2021005421A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862769413P 2018-11-19 2018-11-19
PCT/US2019/062045 WO2020106636A1 (en) 2018-11-19 2019-11-18 C11-cyclic substituted 13-membered macrolides and uses thereof

Publications (1)

Publication Number Publication Date
MX2021005421A true MX2021005421A (es) 2021-09-21

Family

ID=68965978

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005421A MX2021005421A (es) 2018-11-19 2019-11-18 Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos.

Country Status (12)

Country Link
US (1) US20220177508A1 (https=)
EP (1) EP3883945A1 (https=)
JP (1) JP2022507795A (https=)
KR (1) KR20210123288A (https=)
CN (1) CN113646319A (https=)
AU (2) AU2019385383B2 (https=)
BR (1) BR112021009607A2 (https=)
CA (1) CA3120235A1 (https=)
IL (2) IL310280A (https=)
MX (1) MX2021005421A (https=)
SG (1) SG11202105228SA (https=)
WO (1) WO2020106636A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023235380A1 (en) * 2022-06-01 2023-12-07 Zikani Therapeutics, Inc. Macrolides for treating genetic diseases
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
KR20250048331A (ko) * 2022-08-11 2025-04-08 지카니 테라퓨틱스, 인크. 치료용 아자케톨라이드 제조용 합성 공정 및 중간체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
BRPI0017013B1 (pt) * 2000-01-27 2015-07-14 Zoetis P Llc Composição de antibiótico azalídeo e método para sua obtenção
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
US8097708B2 (en) * 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
US20130102551A1 (en) * 2010-07-01 2013-04-25 Andreas Hotte Antibiotic compositions
JP6437523B2 (ja) * 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN106998685A (zh) * 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (en) * 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof

Also Published As

Publication number Publication date
BR112021009607A2 (pt) 2021-08-10
IL283185B2 (en) 2024-06-01
CN113646319A (zh) 2021-11-12
IL310280A (en) 2024-03-01
IL283185B1 (en) 2024-02-01
EP3883945A1 (en) 2021-09-29
SG11202105228SA (en) 2021-06-29
US20220177508A1 (en) 2022-06-09
WO2020106636A1 (en) 2020-05-28
JP2022507795A (ja) 2022-01-18
AU2019385383A1 (en) 2021-07-01
AU2019385383B2 (en) 2023-06-15
KR20210123288A (ko) 2021-10-13
IL283185A (en) 2021-06-30
AU2023229518A1 (en) 2023-09-28
CA3120235A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
AU2018338608A1 (en) Methods, compositions, and implantable elements comprising active cells
WO2018190719A3 (en) Anti-sirp alpha antibodies
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
SE1550189A1 (en) Therapeutic and prophylactic composition produced by microbiota
MX2021005421A (es) Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos.
NZ730803A (en) Methods for the preparation of ribosides
WO2016198531A3 (en) Hpv vaccines
PH12019502782A1 (en) Fixed dose formulations
WO2015138716A3 (en) Anti-infective and osteogenic compositions and methods of use
MX2016015218A (es) Antibioticos macrociclicos de amplio espectro.
PH12019500083A1 (en) Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections
WO2017160944A3 (en) Compositions and methods for treating and preventing graft versus host disease
WO2017024059A8 (en) Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use
WO2019032936A8 (en) LINCONSAMIDE ANTIBIOTICS AND USES THEREOF
MY201687A (en) C-mannoside compounds useful for the treatment of urinary tract infections
MX2018006190A (es) Antibioticos de amplio espectro macrociclico.
WO2015173701A3 (en) Pharmaceutical compositions comprising danirixin for treating infectious diseases
MX2021005423A (es) Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos.
MX2022001261A (es) Derivados de dihidropirimidina y usos de los mismos en el tratamiento de infeccion por vhb o de enfermedades inducidas por vhb.
MX2023005913A (es) Derivados de bencenosulfonamida y usos de los mismos.
PH12019501904A1 (en) Macrocyclic broad spectrum antibiotics
WO2015048188A3 (en) Modified fibroblast growth factors for the treatment of ocular disorders
CA3011003A1 (en) Bacterial ghosts for the treatment of cancer
PH12021550121A1 (en) Methods of treating hfpef employing dapagliflozin and compositions comprising the same
WO2016066722A3 (en) Bacteriophage combinations for human or animal therapy